{
    "q": [
        {
            "docid": "3474896_38",
            "document": "Magnesium transporter . The MNR2 gene encodes a protein closely related to the Alr proteins, but includes conserved features that define a distinct subgroup of CorA proteins in fungal genomes, suggesting a distinct role in Mg homeostasis. Like an alr1 mutant, growth of an mnr2 mutant was sensitive to Mg-deficient conditions, but the mnr2 mutant was observed to accumulate more Mg than a wild-type strain under these conditions. These phenotypes suggested that Mnr2 may regulate Mg storage within an intracellular compartment. Consistent with this interpretation, the Mnr2 protein was localized to the membrane of the vacuole, an internal compartment implicated in the storage of excess mineral nutrients by yeast. A direct role of Mnr2 in Mg transport was suggested by the observation that increased Mnr2 expression, which redirected some Mnr2 protein to the cell surface, also suppressed the Mg-requirement of an alr1 alr2 double mutant strain. Interestingly, the mnr2 mutation also altered accumulation of other divalent cations, suggesting this mutation may increase Alr gene expression or protein activity. Recent work supported this model, by showing that Alr1 activity was increased in an mnr2 mutant strain, and that the mutation was associated with induction of Alr1 activity at a higher external Mg concentration than was observed for an Mnr2 wild-type strain. These effects were observed without any change in Alr1 protein accumulation, again indicating that Alr1 activity may be regulated directly by the Mg concentration within the cell.",
            "score": 112.01234531402588
        },
        {
            "docid": "1686272_18",
            "document": "Chemical biology . Protein misfolding has previously been studied using both computational approaches as well as \"in vivo\" biological assays in model organisms such as \"Drosophila melanogaster\" and \"C. elegans\". Computational models use a \"de novo\" process to calculate possible protein structures based on input parameters such as amino acid sequence, solvent effects, and mutations. This method has the shortcoming that the cell environment has been drastically simplified, which limits the factors that influence folding and stability. On the other hand, biological assays can be quite complicated to perform \"in vivo\" with high-throughput like efficiency and there always remains the question of how well lower organism systems approximate human systems. Dobson et al. propose combining these two approaches such that computational models based on the organism studies can begin to predict what factors will lead to protein misfolding. Several experiments have already been performed based on this strategy. In experiments on \"Drosophila\", different mutations of beta amyloid peptides were evaluated based on the survival rates of the flies as well as their motile ability. The findings from the study show that the more a protein aggregates, the more detrimental the neurological dysfunction. Further studies using transthyretin, a component of cerebrospinal fluid that binds to beta amyloid peptide deterring aggregation but can itself aggregate especially when mutated, indicate that aggregation prone proteins may not aggregate where they are secreted and rather are deposited in specific organs or tissues based on each mutation. Kelly et al. have shown that the more stable, both kinetically and thermodynamically, a misfolded protein is the more likely the cell is to secrete it from the endoplasmic reticulum rather than targeting the protein for degradation. In addition, the more stress that a cell feels from misfolded proteins the more probable new proteins will misfold. These experiments as well as others having begun to elucidate both the intrinsic and extrinsic causes of misfolding as well as how the cell recognizes if proteins have folded correctly.",
            "score": 158.44830965995789
        },
        {
            "docid": "624361_37",
            "document": "Autophagy . Parkinson disease is a neurodegenerative disorder partially caused by the cell death of brain and brain stem cells in many nuclei like the substantia nigra. Parkinson\u2019s disease is characterized by inclusions of a protein called alpha-synuclien (Lewy bodies) in affected neurons that cells cannot break down. Deregulation of the autophagy pathway and mutation of alleles regulating autophagy are believed to cause neurodegenerative diseases. Autophagy is essential for neuronal survival. Without efficient autophagy, neurons gather ubiquitinated protein aggregates and degrade. Ubiquitinated proteins are proteins that have been tagged with ubiquitin to get degraded. Mutations of synuclien alleles lead to lysosome pH increase and hydrolase inhibition. As a result, lysosomes degradative capacity is decreased. There are several genetic mutations implicated in the disease, including loss of function PINK1 and Parkin. Loss of function in these genes can lead to damaged mitochondrial accumulation and protein aggregates than can lead to cellular degeneration. Mitochondria is involved in Parkinson's disease. In idiopathic Parkinson's disease, the disease is commonly caused by dysfunctional mitochondria, cellular oxidative stress, autophagic alterations and the aggregation of proteins. These can lead to mitochondrial swelling and depolarization.",
            "score": 241.86247384548187
        },
        {
            "docid": "3572611_5",
            "document": "HRAS . HRAS has been shown to be a proto-oncogene. When mutated, proto-oncogenes have the potential to cause normal cells to become cancerous. Some gene mutations are acquired during a person's lifetime and are present only in certain cells. These changes are called somatic mutations and are not inherited. Somatic mutations in the HRAS gene in bladder cells have been associated with bladder cancer. One specific mutation has been identified in a significant percentage of bladder tumors; this mutation substitutes one protein building block (amino acid) for another amino acid in the HRAS protein. Specifically, the mutation replaces the amino acid glycine with the amino acid valine at position 12 (written as Gly12Val, G12V, or H-RasV). The altered HRAS protein is permanently activated within the cell. This overactive protein directs the cell to grow and divide in the absence of outside signals, leading to uncontrolled cell division and the formation of a tumor. Mutations in the HRAS gene also have been associated with the progression of bladder cancer and an increased risk of tumor recurrence after treatment.",
            "score": 99.87082695960999
        },
        {
            "docid": "611074_9",
            "document": "Point mutation . Missense mutations code for a different amino acid. A missense mutation changes a codon so that a different protein is created, a non-synonymous change. Conservative mutations result in an amino acid change. However, the properties of the amino acid remain the same (e.g., hydrophobic, hydrophilic, etc.). At times, a change to one amino acid in the protein is not detrimental to the organism as a whole. Most proteins can withstand one or two point mutations before their function changes. Non-conservative mutations result in an amino acid change that has different properties than the wild type. The protein may lose its function, which can result in a disease in the organism. For example, sickle-cell disease is caused by a single point mutation (a missense mutation) in the beta-hemoglobin gene that converts a GAG codon into GUG, which encodes the amino acid valine rather than glutamic acid. The protein may also exhibit a \"gain of function\" or become activated, such is the case with the mutation changing a valine to glutamic acid in the braf gene; this leads to an activation of the RAF protein which causes unlimited proliferative signalling in cancer cells. These are both examples of a non-conservative (missense) mutation.",
            "score": 97.96898007392883
        },
        {
            "docid": "14873446_4",
            "document": "KDELR1 . KDEL receptors have been implicated in the development of dilated cardiomyopathy (DCM). To determine the relationship between KDEL receptor and dilated cardiomyopathy, transgenic mice with a point mutation (D193N) were made. The mice expressing the transport mutant D193N gene grew normally until they reached adulthood. The mutant KDEL receptor did not function after 14 weeks of age, and these mice developed DCM. They were observed to have dilated heart chambers, as well as higher heart-to-body ratios with enlarged hearts, and the cardiac myocytes were larger in size. No difference was observed in arterial blood pressure between wild-type and mutant mice, thus cardiomegaly was not attributed to hypertension. Upon analysis, it was found that KDEL mutant mice had proliferation in their sarcoplasmic reticulum (SR) and a narrowing in the transverse tubule compared to the wild-type and controls. Moreover, aggregations of degenerative membrane proteins were observed in the expanded SR. This suggests that the mutant KDEL receptor leads to impaired recycling and quality control of the ER, which leads to aggregation of misfolded proteins in the ER. Furthermore, KDEL D193N transgenic mice had defects in the L-type Ca++ channel current in ventricular myocytes. The basal current of these channels was significantly lower than the controls. L-type channels expression was lower in the plasma membrane of the KDEL D193N heart cells due to the narrowing of transverse tubules. BiP, a chaperone protein, was unevenly distributed and synthesized in larger proportion in the transgenic mutant mice, which suggests that there was an increase in concentration of misfolded proteins. They also observed aggregates of the ubiquitin-proteasome system (a degradation system); this suggests that there was saturation of the system due to the high levels of misfolded proteins that lead to impaired ER quality control. The researchers concluded that hyperubiquitination and saturation of the proteasome system results due to the accumulation of misfolded protein, which induces stress. The accumulation of misfolded proteins induced by ER stress has also been observed in human DCM. A murine DCM study found an increase in apoptosis due to the high levels of CHOP expression. CHOP is a transcription factor that is elevated during ER stress and causes apoptosis of cells during the process of an unfolded protein response. Increase pressure load/mechanical stress in KDEL D193N mice caused an even greater synthesis of BiP, CHOP and other proteins that are biomarkers of cellular stress and ER stress as the capacity of the ER to deal with this is very limited.",
            "score": 122.40251886844635
        },
        {
            "docid": "39510164_4",
            "document": "Mutagenesis (molecular biology technique) . Early approaches to mutagenesis rely on methods which are entirely random in the mutations produced. Cells or organisms may be exposed to mutagens such as UV radiation or mutagenic chemicals, and mutants with desired characteristics are then selected. Hermann Muller discovered that x-rays can cause genetic mutations in fruit flies (published in 1927), and went on to use the \"Drosophila\" mutants created for his studies on genetics. For \"Escherichia coli\", mutants may be selected first by exposure to UV radiation, then plated onto agar medium. The colonies formed are then replica-plated, one in rich medium, another in minimal medium, and mutants that have specific nutritional requirements can then be identified by their inability to grow in minimal medium. Similar procedures may be repeated with other types of cells and with different media for selection. A number of methods for generating random mutations in specific proteins were later developed to screen for mutants with interesting or improved properties. These methods may involve the use of doped nucleotides in oligonucleotides synthesis, or conducting a PCR reaction in conditions that enhance misincorporation of nucleotides (error-prone PCR), for example by reducing the fidelity of replication or using nucleotide analogues. A variation of this method for integrating non-biased mutations in a gene is the Sequence Saturation Mutagenesis. PCR products which contain mutation(s) are then cloned into an expression vector and the mutant proteins produced can then be characterised.",
            "score": 120.067187666893
        },
        {
            "docid": "39066649_4",
            "document": "Doubletime (gene) . Young named the novel gene double-time (\"dbt\") due to its effect on the normal period of Drosophila. Mutant flies which only expressed \"dbt\" had an 18-hour period while those expressing \"dbt\" had a 28-hour period. In addition, Young\u2019s team isolated a third allele, \"dbt\"' which caused lethality in pupa while ablating any \"per\" or \"tim\" products in larvae. \"dbt\" mutants were important because they provided clues as to how the gene product functioned. Without functional DBT protein, flies accumulated high levels of PER and these PER proteins do not disintegrate in the absence of pairing with TIM protein. These mutants expressed higher cytosolic levels of PER than cells in which PER protein was associated with TIM protein. The double-time gene regulates the expression of PER which in turns controls circadian rhythm. Young\u2019s team later cloned the dbt gene and found that the DBT protein was a kinase which specifically phosphorylated PER proteins. Thus, in dbt mutants, PER proteins were not phosphorylated by DBT protein.",
            "score": 155.91740226745605
        },
        {
            "docid": "572637_10",
            "document": "Guanylate cyclase . Cone dystrophy (COD) is a retinal degradation of photoreceptor function wherein cone function is lost at the onset of the dystrophy but rod function is preserved until almost the end. COD has been linked to several genetic mutations including mutations in the guanylate cyclase activator 1A (GUCA1A) and guanylate cyclase 2D (GUY2D) among other enzymes. To be specific, GUY2D codes for RETGC-1, which is involved in cone adaptation and photoreceptor sensitivity by synthesizing cGMP. Low concentrations of calcium cause the dimerization of RETGC-1 proteins through stimulation from guanylate cyclase-activating proteins (GCAP). This process happens at amino acids 817-857, and mutations in this region increase RETGC-1 affinity for GCAP. This works to alter the calcium sensitivity of the neuron by allowing mutant RETGC-1 to be activated by GCAP at higher calcium levels than the wild-type. Because RETGC-1 produces cGMP, which keeps cyclic nucleotide-gated channels open allowing the influx of calcium, this mutation causes extremely high intracellular calcium levels. Calcium, which plays many roles in the cell and is tightly regulated, disrupts the membrane when it appears in excess. Also, calcium is linked to apoptosis by causing the release of cytochrome c. Therefore, mutations in the RETGC-1 can cause COD by increasing intracellular calcium levels and stimulating cone photoreceptor death.",
            "score": 87.06821060180664
        },
        {
            "docid": "6060319_11",
            "document": "Von Hippel\u2013Lindau tumor suppressor . HIF can help explain the organ specific nature of VHL syndrome. It has been theorized that constitutively activating HIF in any cell could lead to cancer, but that there are redundant regulators of HIF in organs not affected by VHL syndrome. This theory has been disproved multiple times since in all cell types loss of VHL function leads to constitutive activation of HIF and its downstream effects. Another theory holds that although in all cells loss of VHL leads to activation of HIF, in \"most\" cells this leads to no advantage in proliferation or survival. Additionally, the nature of the mutation in the VHL protein leads to phenotypic manifestations in the pattern of cancer that develops. Nonsense or deletion mutations of VHL protein have been linked to type 1 VHL with a low risk of pheochromocytoma (adrenal gland tumors). Type 2 VHL has been linked to missense mutations and is linked to a high risk of pheochromocytoma. Type 2 has also been further subdivided based on risks of renal cell carcinoma. In types 1, 2A and 2B the mutant pVHL is defective in HIF regulation, while type 2C mutant are defective in protein kinase C regulation. These genotype\u2013phenotype correlations suggest that missense mutations of pVHL lead to a 'gain of function' protein.",
            "score": 109.0399100780487
        },
        {
            "docid": "624361_18",
            "document": "Autophagy . Autophagy has roles in various cellular functions. One particular example is in yeasts, where the nutrient starvation induces a high level of autophagy. This allows unneeded proteins to be degraded and the amino acids recycled for the synthesis of proteins that are essential for survival. In higher eukaryotes, autophagy is induced in response to the nutrient depletion that occurs in animals at birth after severing off the trans-placental food supply, as well as that of nutrient starved cultured cells and tissues. Mutant yeast cells that have a reduced autophagic capability rapidly perish in nutrition-deficient conditions. Studies on the \"apg\" mutants suggest that autophagy via autophagic bodies is indispensable for protein degradation in the vacuoles under starvation conditions, and that at least 15 APG genes are involved in autophagy in yeast. A gene known as ATG7 has been implicated in nutrient-mediated autophagy, as mice studies have shown that starvation-induced autophagy was impaired in \"atg7\"-deficient mice.",
            "score": 182.63775825500488
        },
        {
            "docid": "29648114_5",
            "document": "Andrea Brand . It was there that Brand conceived of the GAL4 system, which Lancet has described as \u201can ingenious toolkit that allows researchers to turn on genes in any cell type and at any time of development, and thus engineer and test the function of both genes and proteins. The effect of this system on fly genetics is hard to exaggerate\u2014one scientist has described it as 'a fly geneticist's Swiss army knife'. By causing cells to express cell death genes\u2014and effectively commit suicide\u2014the system can model diabetes by killing insulin-producing cells. 'It has also been used to express mutant versions of proteins to model neurodegenerative diseases, such as Alzheimer's', says Brand. Now the most highly cited paper in the Drosophila field, Brand had enormous difficulty in getting the paper published.\u201d Lancet notes that the GAL4 system remains \u201cat the heart of Brand's current work on Drosophila neural stem cells. Because of the similarities between Drosophila and mammalian neural stem cells in their ability to self-renew and differentiate into different types of neurons and glial cells, the work has the potential to help develop therapies for neurodegenerative diseases such as Parkinson's.\u201d",
            "score": 124.74026370048523
        },
        {
            "docid": "39981969_11",
            "document": "Hereditary sensory and autonomic neuropathy type I . Initially, mutations in the \"SPTLC1\" gene were associated with increased activity of SPT. Subsequent studies rather suggested that the mutations reduce the activity of the enzyme. However, it cannot account for the aberrant sphingolipid-related cellular features in heterozygous patient-derived cells or the HSAN IA clinical features in heterozygous mice. These results suggest that the activity of non-mutant SPTLC1 protein may be sufficient for maintaining normal sphingolipid biosynthesis and cell viability. Therefore, the neuronal degeneration in HSAN IA is likely due to subtler and rather long-term effects of the mutations or perhaps accumulation of toxic lipids produced by mutant enzymes.",
            "score": 91.96602392196655
        },
        {
            "docid": "854294_15",
            "document": "DNA repair . In contrast to DNA damage, a mutation is a change in the base sequence of the DNA. A mutation cannot be recognized by enzymes once the base change is present in both DNA strands, and thus a mutation cannot be repaired. At the cellular level, mutations can cause alterations in protein function and regulation. Mutations are replicated when the cell replicates. In a population of cells, mutant cells will increase or decrease in frequency according to the effects of the mutation on the ability of the cell to survive and reproduce.",
            "score": 99.39035868644714
        },
        {
            "docid": "14754943_3",
            "document": "SNAI1 . The Drosophila embryonic protein SNAI1, commonly known as Snail, is a zinc finger transcriptional repressor which downregulates the expression of ectodermal genes within the mesoderm. The nuclear protein encoded by this gene is structurally similar to the Drosophila snail protein, and is also thought to be critical for mesoderm formation in the developing embryo. At least two variants of a similar processed pseudogene have been found on chromosome 2. SNAI1 zinc-fingers (ZF) binds to E-box, an E-cadherin promoter region, and represses the expression of the adhesion molecule, which induces the tightly bound epithelial cells to break loose from each other and migrate into the developing embryo to become mesenchymal cells. This process allows for the formation of the mesodermal layer in the developing embryo. Though SNAI1 is shown to repress expression of E-cadherin in epithelial cells, studies have shown homozygous mutant embryos are still able to form a mesodermal layer. However, the mesodermal layer present shows characteristics of epithelial cells and not mesenchymal cells (the mutant mesoderm cells exhibited a polarized state). Other studies show that mutation of specific ZFs contribute to a decrease in SNAI1 E-cadherin repression.",
            "score": 101.2671172618866
        },
        {
            "docid": "39510164_2",
            "document": "Mutagenesis (molecular biology technique) . Mutagenesis in the laboratory is an important technique whereby DNA mutations are deliberately engineered to produce mutant genes, proteins, strains of bacteria, or other genetically modified organisms. Various constituents of a gene, such as its control elements and its gene product, may be mutated so that the functioning of a gene or protein can be examined in detail. The mutation may also produce mutant proteins with interesting properties, or enhanced or novel functions that may be of commercial use. Mutant strains may also be produced that have practical application or allow the molecular basis of particular cell function to be investigated.",
            "score": 105.59986996650696
        },
        {
            "docid": "10975535_7",
            "document": "SKI protein . The SKI oncogene is present in all cells, and is commonly active during development. Specifically, avian fibroblasts depend on the SKI protein as a transcription co-regulator inducing transformation. The aforementioned DHD region is specifically employed for protein-protein interactions, while the 191 amino acid C terminus mediates oligomerization. Recent research shows that the SKI protein in cancerous cells acts as a suppressor, inhibiting transforming growth factor \u03b2 (TGF- \u03b2) signaling. TGF- \u03b2 is a protein which regulates cell growth. Signaling is regulated by a family of proteins called the Smad proteins. SKI is present in all adult and embryonic cells at low levels, however an over expression of the protein is characteristic of tumor cells. It is thought that high levels of SKI protein inactivate tumor suppression by displacement of other proteins and interference with the signaling pathway of TGF- \u03b2. The SKI protein and the CPB protein compete for binding with the Smad proteins, specifically competing with the Smad-3 and CReB-binding protein interactions. SKI also directly interacts with the R-Smad \u2219 Smad-4 complex, which directly represses normal transcription of the TGF-\u03b2 responsive genes, inactivating the cell\u2019s ability to stop growth and division, creating cancerous cells.",
            "score": 113.17867052555084
        },
        {
            "docid": "16818636_6",
            "document": "Mouse model of colorectal and intestinal cancer . Mice with mutations in transforming growth factor-\u03b21 gene introduced into 129/Sv Rag2 mutant mouse accelerates adenocarcinomas with strong local invasion suggesting a role for genetic background in tumor development. Colon-specific expression of activated mutant of K-ras (protein)  (K-ras) results in development of single or multiple lesions. Oncogenic K-ras allele activated in colon epithelium induces expression of procarcinogenic protein kinase C-\u03b2II (PKC\u03b2II) and increases cell proliferation of epithelial cells, while in the distal colon the mutant form of K-ras has the opposite effects on PKC\u03b2II expression and cell proliferation. Treatment of this mouse model with the procarcinogen azoxymethane (AOM) leads to formation of dysplastic microadenomas in the proximal but not in the distal colon. Thus the K-ras mutant is a valuable mouse model of proximal colon carcinogenesis. Mutation in the \"Muc2\" gene causes adenomas and adenocarcinomas in the intestine of mice.",
            "score": 79.56254005432129
        },
        {
            "docid": "466746_10",
            "document": "Mycoplasma pneumoniae . Adherence of \"M. pneumoniae\" to a host cell (usually a respiratory tract cell, but occasionally an erythrocyte or urogenital lining cell) is the initiating event for pneumonic disease and related symptoms. The specialized attachment organelle is a polar, electron dense and elongated cell extension that facilitates motility and cytadherence to host cells. It is composed of a central filament surrounded by an intracytoplasmic space, along with a number of adhesins and structural and accessory proteins localized at the tip of the organelle. A variety of proteins are known to contribute to the formation and functionality of the attachment organelle, including the accessory proteins HMW1\u2013HMW5, P30, P56, and P90 that confer structure and adhesin support, and P1, P30 and P116 which are involved directly in attachment. This network of proteins participates not only in the initiation of attachment organelle formation and adhesion but also in motility.  The P1 adhesin (trypsin-sensitive protein) is a 120 kDa protein highly clustered on the surface of the attachment organelle tip in virulent mycoplasmas. Both the presence of P1 and its concentration on the cell surface are required for the attachment of \"M. pneumoniae\" to the host cell. \"M. pneumoniae\" cells treated with monoclonal antibodies specific to the immunogenic C-terminus of the P1 adhesin have been shown to be inhibited in their ability to attach to the host cell surface by approximately 75%, suggesting P1 is a major component in cytadherence. These antibodies also decreased the ability of the cell to glide quickly, which may contribute to decreased adherence to the host by hindering their capacity to locate a host cell. Furthermore, mutations in P1 or degradation by trypsin treatment yield avirulent \"M. pneumoniae\" cells. Loss of proteins in the cytoskeleton involved in the localization of P1 in the tip structure, such as HMW1\u2013HMW3, also cause avirulence due to the lack of adhesin clustering. Another protein considered to play an important role in cytadherence is P30, as \"M. pneumoniae\" cells with mutations in this protein or that have had antibodies raised against P30 are incapable of adhering to host cells. P30 is not involved in the localization of P1 in the tip structure since P1 is trafficked to the attachment organelle in P30 mutants, but rather it may function as a receptor-binding accessory adhesin. P30 mutants also display distinct morphological features such as multiple lobes and a rounded shape as opposed to elongated, which suggests P30 may interact with the cytoskeleton during formation of the attachment organelle. A number of eukaryotic cell surface components have been implicated in the adherence of \"M. pneumoniae\" cells to the respiratory tract epithelium. Among them are sialoglycoconjugates, sulfated glycolipids, glycoproteins, fibronectin, and neuraminic acid receptors. Lectins on the surface of the bacterial cells are capable of binding oligosaccharide chains on glycolipids and glycoproteins to facilitate attachment, in addition to the proteins TU and pyruvate dehydrogenase E1 \u03b2, which bind to fibronectin.",
            "score": 109.39742171764374
        },
        {
            "docid": "564779_4",
            "document": "Cell growth . The relationship between cell size and cell division has been extensively studied in yeast. For some cells, there is a mechanism by which cell division is not initiated until a cell has reached a certain size. If the nutrient supply is restricted (after time t = 2 in the diagram, below), and the rate of increase in cell size is slowed, the time period between cell divisions is increased. Yeast cell-size mutants were isolated that begin cell division before reaching a normal/regular size (\"wee\" mutants). Wee1 protein is a tyrosine kinase that normally phosphorylates the Cdc2 cell cycle regulatory protein (the homolog of CDK1 in humans), a cyclin-dependent kinase, on a tyrosine residue. Cdc2 drives entry into mitosis by phosphorylating a wide range of targets. This covalent modification of the molecular structure of Cdc2 inhibits the enzymatic activity of Cdc2 and prevents cell division. Wee1 acts to keep Cdc2 inactive during early G2 when cells are still small. When cells have reached sufficient size during G2, the phosphatase Cdc25 removes the inhibitory phosphorylation, and thus activates Cdc2 to allow mitotic entry. A balance of Wee1 and Cdc25 activity with changes in cell size is coordinated by the mitotic entry control system. It has been shown in Wee1 mutants, cells with weakened Wee1 activity, that Cdc2 becomes active when the cell is smaller. Thus, mitosis occurs before the yeast reach their normal size. This suggests that cell division may be regulated in part by dilution of Wee1 protein in cells as they grow larger.",
            "score": 139.90395617485046
        },
        {
            "docid": "896294_6",
            "document": "Paul Greengard . Greengard's research has focused on events inside the neuron caused by neurotransmitters. Specifically, Greengard and his fellow researchers studied the behavior of second messenger cascades that transform the docking of a neurotransmitter with a receptor into permanent changes in the neuron. In a series of experiments, Greengard and his colleagues showed that when dopamine interacts with a receptor on the cell membrane of a neuron, it causes an increase in cyclic AMP inside the cell. This increase of cyclic AMP, in turn activates a protein called protein kinase A, which turns other proteins on or off by adding phosphate groups in a reaction known as phosphorylation. The proteins activated by phosphorylation can then perform a number of changes in the cell: transcribing DNA to make new proteins, moving more receptors to the synapse (and thus increasing the neuron's sensitivity), or moving ion channels to the cell surface (and thus increasing the cell's excitability). He was awarded the Nobel Prize in 2000 \"for showing how neurotransmitters act on the cell and can activate a central molecule known as DARPP-32\".",
            "score": 152.30030941963196
        },
        {
            "docid": "2792071_4",
            "document": "Neurofibromatosis type II . NF II is caused by a defect in the gene that normally gives rise to a product called \"Merlin\" or \"Schwannomin\", located on chromosome 22 band q11-13.1. This peptide is thought to have a tumor-suppressive function. In a normal cell, the concentrations of active (dephosphorylated) merlin are controlled by processes such as cell adhesion (which would indicate the need to restrain cell division). It is known that Merlin's deficiency can result in unmediated progression through the cell cycle due to the lack of contact-mediated tumour suppression, sufficient to result in the tumors characteristic of Neurofibromatosis type II. Mutations of NF II is presumed to result in either a failure to synthesize Merlin or the production of a defective peptide that lacks the normal tumor-suppressive effect. The Schwannomin-peptide consists of 595 amino acids. Comparison of Schwannomin with other proteins shows similarities to proteins that connect the cytoskeleton to the cell membrane. Mutations in the Schwannomin-gene are thought to alter the movement and shape of affected cells with loss of contact inhibition. Ependymomas are tumors arising from the ependyma, an epithelium-like tissue of the central nervous system. In patients with NF2 and ependymomas, the tumor suppressant function of Merlin may be compromised. Loss of function mutations occurring in chromosome 22q, where Merlin proteins are coded, can promote tumorigenesis, or the creation of new tumorous cells. Deletions, too, in the NH2-terminal domain of merlin proteins have been associated with early tumor onset and poor prognosis in affected patients.",
            "score": 117.00003516674042
        },
        {
            "docid": "3451732_29",
            "document": "PRNP . The conversion of PrP to PrP conformation is the mechanism of transmission of fatal, neurodegenerative transmissible spongiform encephalopathies (TSE). This can arise from genetic factors, infection from external source, or spontaneously for reasons unknown. Accumulation of PrP corresponds with progression of neurodegeneration and is the proposed cause. Some PRNP mutations lead to a change in single amino acids (the building-blocks of proteins) in the prion protein. Others insert additional amino acids into the protein or cause an abnormally short protein to be made. These mutations cause the cell to make prion proteins with an abnormal structure. The abnormal protein PrP accumulates in the brain and destroys nerve cells, which leads to the mental and behavioral features of prion diseases.",
            "score": 135.99687123298645
        },
        {
            "docid": "5617_6",
            "document": "Creutzfeldt\u2013Jakob disease . The CJD prion is dangerous because it promotes refolding of native prion protein into the diseased state. The number of misfolded protein molecules will increase exponentially and the process leads to a large quantity of insoluble protein in affected cells. This mass of misfolded proteins disrupts neuronal cell function and causes cell death. Mutations in the gene for the prion protein can cause a misfolding of the dominantly alpha helical regions into beta pleated sheets. This change in conformation disables the ability of the protein to undergo digestion. Once the prion is transmitted, the defective proteins invade the brain and induce other prion protein molecules to misfold in a self-sustaining feedback loop. These neurodegenerative diseases are commonly called \"prion diseases\".",
            "score": 133.6658968925476
        },
        {
            "docid": "3572611_4",
            "document": "HRAS . At least five inherited mutations in the HRAS gene have been identified in people with Costello syndrome. Each of these mutations changes an amino acid in a critical region of the HRAS protein. The most common mutation replaces the amino acid glycine with the amino acid serine at position 12 (written as Gly12Ser or G12S). The mutations responsible for Costello syndrome lead to the production of an HRAS protein that is permanently active. Instead of triggering cell growth in response to particular signals from outside the cell, the overactive protein directs cells to grow and divide constantly. This uncontrolled cell division can result in the formation of noncancerous and cancerous tumors. Researchers are uncertain how mutations in the HRAS gene cause the other features of Costello syndrome (such as mental retardation, distinctive facial features, and heart problems), but many of the signs and symptoms probably result from cell overgrowth and abnormal cell division.",
            "score": 107.62394165992737
        },
        {
            "docid": "2354497_3",
            "document": "Heat shock . The cellular response to heat shock damage, the heat shock response, includes the transcriptional up-regulation of genes encoding heat shock proteins (HSPs) as part of the cell's internal repair mechanism. The effects of stressors such as temperature changes and toxins are counteracted by these HSPs, that upon activation respond to heat, cold and oxygen deprivation by activating several cascade pathways. HSPs are also present in cells under perfectly normal conditions, but an elevation in stress levels for the cell promotes an increase in their production levels by activating heat-shock genes at levels higher than normal. Some HSPs, called chaperones, also have increased production levels when the cell faces various stress factors. Chaperone's functions includes making sure that the cell\u2019s proteins are properly folded in the correct conformation and they ensure this by facilitating protein folding using their substrate binding domain. An example of chaperons are the HSP70 (heat shock protein) chaperones. For example, HSPs help new or misfolded proteins to fold into their correct three-dimensional conformations, which is essential for their function. They also shuttle proteins from one compartment to another inside the cell, and target old or terminally misfolded proteins to proteases for degradation. Heat shock proteins are also believed to play a role in the presentation of pieces of proteins (or peptides) on the cell surface to help the immune system recognize diseased cells. 5 major families of HSPs are recognized: the Hsp70 (DnaK) family, the chaperonins (GroEL and Hsp60), the Hsp90 family, the Hsp100 (Clp) family and the small HSP (sHSP) family. Other proteins such as, protein disulfide isomerase and calnexin/calreticulin, have chaperone functions and assist protein folding in the Endoplasmic Reticulum.",
            "score": 136.92278242111206
        },
        {
            "docid": "24011348_3",
            "document": "Scrambler mouse . The spontaneous autosomal recessive scrambler mutation on chromosome 4 causes a deficiency of DAB1, encoding disabled-1, a protein involved in the signaling of the Reelin protein, lacking in the reeler mutant, Dab1-scm homozygous mutants possess a reeler-like phenotype with respect to cell malpositioning in cerebellar cortex, hippocampus, and neocortex. Purkinje cell and granule cell degeneration results in ataxia. Despite normal Reln mRNA levels, Dab1-scm mutants have defective reelin signaling, indicating that disabled-1 acts downstream of reelin. Cell ectopias are identical with targeted disruption of Dab1.",
            "score": 98.97028923034668
        },
        {
            "docid": "18647261_3",
            "document": "Protective autoimmunity . The adaptive immune system primarily consists of T and B cells (lymphocytes), which can respond to specific antigens and subsequently acquire an immunological memory. The activity of adaptive immunity is critically important for host defense against pathogens. Cells of the adaptive immunity that respond to self-antigens are termed \u2018autoimmune cells\u2019. Autoimmunity, the activity of autoimmune cells, is generally considered in the context of an autoimmune disease\u2014a pathological condition induced by an overwhelming activity of autoimmune cells. One of the hallmarks of immunity is the ability to transfer a substantial amount of lymphocytes or antibodies from one animal to another in a way that results in immunity to a certain pathogen (adaptive transfer). Similarly, autoimmune diseases can be induced experimentally by the adaptive transfer of autoimmune cells or antibodies from an animal that suffers from an autoimmune disease into a healthy animal. In a seminal study of 1999, Schwartz and colleagues demonstrated that the same autoimmune T cells that can cause an experimental autoimmune encephalomyelitis (EAE, a common model for multiple sclerosis) can also be harnessed to protect injured CNS tissue from secondary degeneration following a traumatic insult. The experiment showed that after a partial crush injury of the optic nerve, rats injected with activated T cells which are specific for myelin basic protein (MBP, a common protein in the CNS) retained 3-fold more retinal ganglion cells with functionally intact axons than did rats injected with activated T cells specific for other (control) antigens. These findings indicated that at least under certain circumstances, autoimmune activity could exert a beneficial effect by protecting injured neurons from the spread of damage. Additional work by the Schwartz group has shown that protective autoimmunity is a naturally occurring physiological phenomenon that takes place spontaneously following a CNS injury. Mutant mice which lack T cells (such as SCID and nude), and mice that lack T cells that can recognize CNS antigens, exhibit reduced levels of neuronal survival following CNS injury relative to normal (wild type) mice. On the other hand, mice that were genetically engineered so that most of their T cells will recognize a CNS antigen\u2014such as transgenic mice overexpressing a T cell receptor (TcR) for MBP\u2014exhibit elevated rates of neuronal survival after CNS injury. Experiments conducted in animal models of spinal cord injury, brain injury, glaucoma, stroke, motor neuron degeneration, Parkinson\u2019s and Alzheimer's disease have demonstrated the relevance of immune cells and in particular T cells that recognize CNS antigens in promoting neuronal survival and functional recovery from acute and chronic neurodegenerative conditions. T cells that recognize CNS antigens have also been shown to be important for maintaining the functional integrity of the adult CNS under normal non-pathological conditions. Immune deficient mice and mice which lack T cells that recognize brain antigens exhibit impairments in spatial learning and memory, and have reduced levels of cell renewal in the hippocampus and sub-ventricular zone (the brain structures where neurogenesis takes place in the adult brain).",
            "score": 137.2451924085617
        },
        {
            "docid": "40707230_3",
            "document": "Phosphomimetics . This chemical similarity can be exploited in cancer, where a protein may mutate into an \"always on\" (constitutively active) state. A mutation may occur to replace a tyrosine (which needs to be phosphorylated in order to activate the protein) with an aspartic acid (which would not need to be phosphorylated). In a laboratory setting, the use of recombinant proteins to artificially introduce phosphomimetics is a common tool for studying phosphorylation and protein activation. For example, the IRF3 protein must be phosphorylated for its normal activity (transcription of its target genes, like IFN\u03b2), but when serine amino acid residues were mutated to aspartic acid, the activity increased 90-fold. Another study found that using phosphomimetic amino acids in PEDF prevented tumor growth by inhibiting angiogenesis and inducing cell death in tumors. Phosphomimetics are commonly used in a gain of function experiment with respect to phosphorylation.",
            "score": 130.6500747203827
        },
        {
            "docid": "19599_25",
            "document": "Mutagenesis . Mutagenesis in the laboratory is an important technique whereby DNA mutations are deliberately engineered to produce mutant genes, proteins, or strains of organism. Various constituents of a gene, such as its control elements and its gene product, may be mutated so that the functioning of a gene or protein can be examined in detail. The mutation may also produce mutant proteins with interesting properties, or enhanced or novel functions that may be of commercial use. Mutant strains may also be produced that have practical application or allow the molecular basis of particular cell function to be investigated.",
            "score": 104.32887315750122
        },
        {
            "docid": "54421246_15",
            "document": "Spinocerebellar ataxia type 1 . The mechanism by which expanded CAG repeat regions in ataxin 1 cause neuronal degeneration is unclear. It was historically believed to be caused by aggregation and deposition of the affected protein similar to other polyglutamine expansion diseases, however rodent model studies have shown significantly later formation of nuclear inclusions of mutant proteins in cerebellum and spinal cord neurons than in cortical and hippocampal neurons which typically show only mild degeneration in SCA1 persons, suggesting a more complicated mechanism. Ataxin-null mice are shown to exhibit reduced motor and spatial learning, suggesting ataxin 1 plays a role in synaptic plasticity and interactions between the motor neurons and the hippocampus. However mice lacking both copies of ataxin 1 do not develop progressive neurological symptoms or show signs of atrophy, suggesting that toxicity of the mutated protein, not loss of function, is the main mechanism for SCA1 pathology. A comparison of mRNA between ataxin null mice and mice with ataxin1 shows that there are common changes in gene expression, including upregulation of genes known to be repressed by an ataxin 1/CIC complex. This suggest that, while not the primary mechanism, a loss of ataxin 1 function contributes to the pathogenesis of SCA1. The loss of function is believed to be caused by an increased affinity for the expanded ataxin 1 for RNA Binding Motif 17, which excludes it from forming its normal complexes with CIC. The gain of function, in turn, is caused by its increased affinity for a number of other proteins.Mutant ataxin-1 also known to alter the neural circuitry of the developing cerebellum, setting the stage for later vulnerability of Purkinje cells, suggesting the existence of non-cell autonomous toxicity.",
            "score": 90.68121945858002
        },
        {
            "docid": "43741187_4",
            "document": "BENTA disease . BENTA disease is caused by germline-encoded gain-of-function mutations in the gene CARD11. This is a 138 kB gene mapping to chromosome 7p22 with 26 exons encoding a 1,154 amino acid protein. The CARD11 protein (also known as CARMA1) is a scaffolding protein required for NF-\u03baB activation in both B and T lymphocytes. Gain-of-function mutations drive constitutive NF-\u03baB activation in both types of cells. Most mutations are localized within or just upstream of the coiled-coil domain (exons 4-9) of the protein. Patient phenotypes also suggest that B cell differentiation might be partially impaired in BENTA disease, contributing to a low percentage of class-switched and memory B cells.",
            "score": 87.91099095344543
        }
    ],
    "r": [
        {
            "docid": "624361_37",
            "document": "Autophagy . Parkinson disease is a neurodegenerative disorder partially caused by the cell death of brain and brain stem cells in many nuclei like the substantia nigra. Parkinson\u2019s disease is characterized by inclusions of a protein called alpha-synuclien (Lewy bodies) in affected neurons that cells cannot break down. Deregulation of the autophagy pathway and mutation of alleles regulating autophagy are believed to cause neurodegenerative diseases. Autophagy is essential for neuronal survival. Without efficient autophagy, neurons gather ubiquitinated protein aggregates and degrade. Ubiquitinated proteins are proteins that have been tagged with ubiquitin to get degraded. Mutations of synuclien alleles lead to lysosome pH increase and hydrolase inhibition. As a result, lysosomes degradative capacity is decreased. There are several genetic mutations implicated in the disease, including loss of function PINK1 and Parkin. Loss of function in these genes can lead to damaged mitochondrial accumulation and protein aggregates than can lead to cellular degeneration. Mitochondria is involved in Parkinson's disease. In idiopathic Parkinson's disease, the disease is commonly caused by dysfunctional mitochondria, cellular oxidative stress, autophagic alterations and the aggregation of proteins. These can lead to mitochondrial swelling and depolarization.",
            "score": 241.8624725341797
        },
        {
            "docid": "38402739_33",
            "document": "MTORC1 . mTORC1's ability to inhibit autophagy while at the same time stimulate protein synthesis and cell growth can result in accumulations of damaged proteins and organelles, contributing to damage at the cellular level. Because autophagy appears to decline with age, activation of autophagy may help promote longevity in humans. Problems in proper autophagy processes have been linked to diabetes, cardiovascular disease, neurodegenerative diseases, and cancer.",
            "score": 222.26515197753906
        },
        {
            "docid": "14797620_9",
            "document": "RPTOR . The mTOR pathway has also been found to be involved in aging. Studies with \"C. elegans\", fruitflies, and mice have shown that the lifespan of the organism is significantly increased by inhibiting mTORC1. mTORC1 phosphorylates Atg13 and stops it from forming the ULK1 kinase complex. This inhibits autophagy, the major degradation pathway in eukaryotic cells. Because mTORC1 inhibits autophagy and stimulates cell growth, it can cause damaged proteins and cell structures to accumulate. For this reason, dysfunction in the process of autophagy can contribute to several diseases, including cancer.",
            "score": 212.63975524902344
        },
        {
            "docid": "48658318_4",
            "document": "David C. Rubinsztein . Rubinsztein has made major contributions to the field of neurodegeneration with his laboratory's discovery that autophagy regulates the levels of intracytoplasmic aggregate-prone proteins that cause many neurodegenerative diseases, including Huntington's, Parkinson's and Alzheimer's disease. His lab has found that autophagy may be inhibited in various neurodegenerative diseases and has elucidated the pathological consequences of autophagy compromise. In addition his research has advanced the basic understanding of autophagy, identifying the plasma membrane as a source of autophagosome membrane and characterising early events in autophagosome biogenesis. Furthermore, he studied how lysosomal positioning regulates autophagy. His goal is to understand the links between these diseases and autophagy. He is currently focused on understanding how to induce autophagy in vivo to remove toxic proteins and avoid the development of neurodegenerative disease",
            "score": 210.2196807861328
        },
        {
            "docid": "640697_37",
            "document": "Reactive oxygen species . Numerous studies have shown the pathways and associations between ROS levels and apoptosis, but a newer line of study has connected ROS levels and autophagy. ROS can also induce cell death through autophagy, which is a self-catabolic process involving sequestration of cytoplasmic contents (exhausted or damaged organelles and protein aggregates) for degradation in lysosomes. Therefore, autophagy can also regulate the cell\u2019s health in times of oxidative stress. Autophagy can be induced by ROS levels through many different pathways in the cell in an attempt to dispose of harmful organelles and prevent damage, such as carcinogens, without inducing apoptosis. Autophagic cell death can be prompted by the over expression of autophagy where the cell digests too much of itself in an attempt to minimize the damage and can no longer survive. When this type of cell death occurs, an increase or loss of control of autophagy regulating genes is commonly co-observed. Thus, once a more in-depth understanding of autophagic cell death is attained and its relation to ROS, this form of programmed cell death may serve as a future cancer therapy. Autophagy and apoptosis are two different cell death mechanisms brought on by high levels of ROS in the cells, however; autophagy and apoptosis rarely act through strictly independent pathways. There is a clear connection between ROS and autophagy and a correlation seen between excessive amounts of ROS leading to apoptosis. The depolarization of the mitochondrial membrane is also characteristic of the initiation of autophagy. When mitochondria are damaged and begin to release ROS, autophagy is initiated to dispose of the damaging organelle. If a drug targets mitochondria and creates ROS, autophagy may dispose of so many mitochondria and other damaged organelles that the cell is no longer viable. The extensive amount of ROS and mitochondrial damage may also signal for apoptosis. The balance of autophagy within the cell and the crosstalk between autophagy and apoptosis mediated by ROS is crucial for a cell\u2019s survival. This crosstalk and connection between autophagy and apoptosis could be a mechanism targeted by cancer therapies or used in combination therapies for highly resistant cancers.",
            "score": 207.42132568359375
        },
        {
            "docid": "30352058_3",
            "document": "Autophagy database . Autophagy is the process by which the cells in an organism destroy non-functional or unnecessary self-components. Specifically, autophagy is a catabolic process involving the degradation of a cell's own components through the lysosomal machinery. Autophagy is also crucial for instances of starvation and removal of potentially dangerous cellular materials, indicating its necessity in maintaining life. As seen in the associated figure \"Autophagy\", cellular products are degraded by destructive cellular components, such as lysosomes, to produce new materials for the cell to use. Research into autophagy and its related processes has exploded over recent years, however, many of these processes processes are not completely understood and homologs have not been found in different species for many of these proteins. Its molecular mechanisms have not been fully elucidated, despite dramatic advances in the field as evidenced by hundreds of autophagy-related genes and proteins reported. As such, there was a demonstrated need for a database to characterize human autophagy proteins and components and/or their homologs, as well as orthologs in other species.",
            "score": 204.15447998046875
        },
        {
            "docid": "50492922_7",
            "document": "Pathophysiology of Parkinson's disease . Autophagy can also clear aggregated protein; however, in neurodegenerative diseases autophagy sometimes cannot break down oligomers fast enough to clear them and maintain regular cell function. Without clearance of protein bundles or other harmful molecules, cells start to alter their function and eventually undergo cell death.",
            "score": 202.26268005371094
        },
        {
            "docid": "624361_24",
            "document": "Autophagy . Autophagy is essential for basal homeostasis; it is also extremely important in maintaining muscle homeostasis during physical exercise. Autophagy at the molecular level is only partially understood. A study of mice shows that autophagy is important for the ever-changing demands of their nutritional and energy needs, particularly through the metabolic pathways of protein catabolism. In a 2012 study conducted by the University of Texas Southwestern Medical Center in Dallas, mutant mice (with a knock-in mutation of BCL2 phosphorylation sites to produce progeny that showed normal levels of basal autophagy yet were deficient in stress-induced autophagy) were tested to challenge this theory. Results showed that when compared to a control group, these mice illustrated a decrease in endurance and an altered glucose metabolism during acute exercise. Another study demonstrated that skeletal muscle fibres of collagen VI knockout mice showed signs of degeneration due to an insufficiency of autophagy which led to an accumulation of damaged mitochondria and excessive cell death. Exercise-induced autophagy was unsuccessful however; but when autophagy was induced artificially post-exercise, the accumulation of damaged organelles in collagen VI deficient muscle fibres was prevented and cellular homeostasis was maintained. Both studies demonstrate that autophagy induction may contribute to the beneficial metabolic effects of exercise and that it is essential in the maintaining of muscle homeostasis during exercise, particularly in collagen VI fibres.",
            "score": 197.1622772216797
        },
        {
            "docid": "14801031_3",
            "document": "ATG4B . Autophagy is the process by which endogenous proteins and damaged organelles are destroyed intracellularly. Autophagy is postulated to be essential for cell homeostasis and cell remodeling during differentiation, metamorphosis, non-apoptotic cell death, and aging. Reduced levels of autophagy have been described in some malignant tumors, and a role for autophagy in controlling the unregulated cell growth linked to cancer has been proposed. This gene encodes a member of the autophagin protein family. The encoded protein is also designated as a member of the C-54 family of cysteine proteases. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. One main function of Atg4 is to cleave the pre-protein of Atg8, leading to the non-lipidated soluble (-I) form which can be processed further by Atg3, Atg7, Atg5-12 into the lipidated form (-II) anchored to the autophagic membrane.",
            "score": 194.56959533691406
        },
        {
            "docid": "27147581_4",
            "document": "Autophagy-related protein 101 . ATG101 is a newly found important autophagy related protein, among many other proteins responsible for autophagy, a process well conserved among most eukaryotic organisms. However, ATG101 is not homologous to any of the other ATG proteins. ATG101 interacts with essential autophagy protein ATG13 in mammals, which is a ULK1 interacting protein. ULK1 (unc-51-like kinase 1) is thought to be important to the activation of macroautophagy in mammals. ATG101 is suggested to protect ATG13 from proteasomal degradation, therefore stabilizing levels of ATG13 found in cells and regulating levels of macroautophagy. According to published papers, ATG101 is said to localize to the isolation membrane, also known as a phagophore. This attachment to the phagophore could possibly explain the palmitoylation site found on the third AA, which is a cysteine. Phagophores are responsible for recognizing and surrounding materials that are to be degraded in the lysosome, by forming a membrane that completely surrounds the materials to be degraded.",
            "score": 192.68739318847656
        },
        {
            "docid": "624361_26",
            "document": "Autophagy . Because autophagy decreases with age and age is a major risk factor for osteoarthritis, the role of autophagy in the development of this disease is suggested. Proteins involved in autophagy are reduced with age in both human and mouse articular cartilage. Mechanical injury to cartilage explants in culture also reduced autophagy proteins. Autophagy is constantly activated in normal cartilage but it is compromised with age and precedes cartilage cell death and structural damage. These results suggest autophagy is a normal protective process (chondroprotection) in the joint.",
            "score": 192.00230407714844
        },
        {
            "docid": "18048149_17",
            "document": "Protein aggregation . In mammalian cells, these protein aggregates are termed \"aggresomes\" and they are formed when the cell is diseased. This is because aggregates tend to form when there are heterologous proteins present in the cell, which can arise when the cell is mutated. The E3 ubiquitin ligase is able to recognize misfolded proteins and ubiquinate them. HDAC6 can then bind to the ubiquitin and the motor protein dynein to bring the marked aggregates to the microtubule organizing center (MTOC). There, they pack together into a sphere that surrounds the MTOC. They bring over chaperones and proteasomes and activate autophagy.",
            "score": 190.1470947265625
        },
        {
            "docid": "38402739_31",
            "document": "MTORC1 . Autophagy is the major degradation pathway in eukaryotic cells and is essential for the removal of damaged organelles via macroautophagy or proteins and smaller cellular debris via microautophagy from the cytoplasm. Thus, autophagy is a way for the cell to recycle old and damaged materials by breaking them down into their smaller components, allowing for the resynthesis of newer and healthier cellular structures. Autophagy can thus remove protein aggregates and damaged organelles that can lead to cellular dysfunction.",
            "score": 189.88018798828125
        },
        {
            "docid": "11422376_7",
            "document": "U1 spliceosomal RNA . U1 snRNP has been implicated in many diseases, especially in those characterized by the presence of misfolded proteins. For instance, a protein component of U1 snRNP called U1-70k from the brain cells of healthy individuals was found to become insoluble in the presence of amyloid aggregates from the brain cells of patients with Alzheimer's disease. U1 overexpression elevates the expression of level of autophagy and alters lysosomal biogenesis",
            "score": 187.63946533203125
        },
        {
            "docid": "12384889_4",
            "document": "Vojo Deretic . The Deretic laboratory has subsequently shown that autophagy in mammalian cells plays not only a degradative role but that it also carries the task of unconventional secretion of cytoplasmic proteins, such as IL-1beta and others including ferritin. This has led to the term \"secretory autophagy\" These proteins normally reside in the cytosol but exert their functions extracellularly. This work, along with the work by others in yeast, extends the influence sphere of autophagy from its canonical roles inside the cell and the confines of the intracellular space to the extracellular space, affecting cell-cell interactions, inflammation, tissue organization, function, and remodeling.",
            "score": 185.12966918945312
        },
        {
            "docid": "624361_29",
            "document": "Autophagy . Several experiments have been done with mice and varying Beclin1, a protein that regulates autophagy. When the Beclin1 gene was altered to be heterozygous (Beclin 1+/-), the mice were found to be tumor prone. However, when Beclin1 was overexpressed, tumor development was inhibited. Care should be exercised when interpreting phenotypes of beclin mutants and attributing the observations to a defect in autophagy, however: Beclin1 is generally required for phosphatidylinositol 3- phosphate production and as such it affects numerous lysosomal and endosomal functions, including endocytosis and endocytic degradation of activated growth factor receptors. In support of the possibility that Beclin1 affects cancer development through an autophagy-independent pathway is the fact that core autophagy factors which are not known to affect other cellular processes and are definitely not known to affect cell proliferation and cell death, such as Atg7 or Atg5, show a much different phenotype when the respective gene is knocked out, which does not include tumor formation. In addition, full knockout of Beclin1 is embryonic lethal whereas knockout of Atg7 or Atg5 is not.",
            "score": 184.73529052734375
        },
        {
            "docid": "10454051_16",
            "document": "Acute myeloblastic leukemia with maturation . Autophagy is an innate pathway used for degradation of cellular components (Kobayashi, 2015). In recent studies, scientists recognize the significance of autophagy both as a potential anti-apoptotic response to cancer treatments as well as a potential mechanism for getting rid of undesirable fusion proteins such as AML1-ETO. In a 2013 study, scientists demonstrated that the degradation of fusion oncoprotein AML1-ETO is not mediated by autophagy through a set of drug dosage trials testing the levels of AML1-ETO protein expression. The acute myeloid leukemia Kasumi-1 cell line was selected for the experiment due to its AML1-ETO positive characteristics. These cells were treated with increasing concentrations of each histone deacetylase inhibitors \u2013 valproic acid (VPA) (epileptic and bipolar drug) or vorinostat (cutaneous T cell lymphoma drug), which are known to induce autophagy associated with loss of the fusion protein. The two inhibitors were added to the cell line in doses of 0, 0.38 uM, 0.74 uM, and 1.5 uM. The cell lysates were then treated with autophagy inhibitors Baf or CQ, or control. Through immunoblotting, there is no reduction of AML1-ETO observed across the different concentrations of VPA or vorinostat. The results indicate that AML1-ETO degradation is not mediated by autophagy, but there is an observed pro-survival autophagy in the leukemic cells (Torgersen et al., 2013). Thus, an inhibition of autophagy would be a viable treatment method for subtype M2 acute myeloid leukemia.",
            "score": 184.33595275878906
        },
        {
            "docid": "42497068_3",
            "document": "ATG4D . Autophagy is the process by which endogenous proteins and damaged organelles are destroyed intracellularly. Autophagy is postulated to be essential for cell homeostasis and cell remodeling during differentiation, metamorphosis, non-apoptotic cell death, and aging. Reduced levels of autophagy have been described in some malignant tumors, and a role for autophagy in controlling the unregulated cell growth linked to cancer has been proposed.",
            "score": 183.82958984375
        },
        {
            "docid": "30352058_4",
            "document": "Autophagy database . Autophagy database is a product of the National Institute of Genetics (NIG) NIG was founded in June 1949 by the ministry of Education, Science, Sports, and Culture, with Prof. Kan Oguma being elected the first director. Over time, many departments have been added for various applications such as Genetics, Genomics, DNA Research, and, most notably for our purposes, the DNA Data Bank. NIG is a division of the Japanese Research Organization of Information and Systems, and is currently under the supervision of its ninth director. NIG aims to conduct top-level research in the pursuit of streamlining of information, as well as the dissemination of information from research into societal application. A tool created by this organization for this purpose is the Autophagy database. The Autophagy database is a database of proteins involved in autophagy. The Autophagy database intends to collect all relevant information, organize it, and make it publicly available so that its users can easily get up-to-date knowledge. Specifically, the Autophagy database offers a \"free-for-all\" tool for those with interests, research and otherwise, in autophagy. To better accomplish this aim, the available Autophagy database from NIG calls for users of the database to disseminate and share information, so that autophagy-related data can be available for free to all who need it. For an interested research community, this model of research dissemination holds promise. As of , there were 582 reviewed proteins available in this database. Including autophagic proteins available in HomoloGene, NCBI, there are over 52,000 total proteins. Autophagy database offers comparison of homologous proteins between 41 different species to search new and old autophagy-related proteins, so that current autophagy research can be streamlined. The database was made publicly available in March 2010 and currently includes 7,444 genes/proteins in 82 eukaryotes.",
            "score": 183.44183349609375
        },
        {
            "docid": "2839255_23",
            "document": "MTOR . The hyperphosphorylation of tau proteins into neurofibrillary tangles is one hallmark of AD. p70S6K activation has been shown to promote tangle formation as well as mTOR hyperactivity through increased phosphorylation and reduced dephosphorylation. It has also been proposed that mTOR contributes to tau pathology by increasing the translation of tau and other proteins. Synaptic plasticity is a key contributor to learning and memory, two processes that are severely impaired in AD patients. Translational control, or the maintenance of protein homeostasis, has been shown to be essential for neural plasticity and is regulated by mTOR. Both protein over- and under-production via mTOR activity seem to contribute to impaired learning and memory. Furthermore, given that deficits resulting from mTOR overactivity can be alleviated through treatment with rapamycin, it is possible that mTOR plays an important role in affecting cognitive functioning through synaptic plasticity. Further evidence for mTOR activity in neurodegeneration comes from recent findings demonstrating that eIF2\u03b1-P, an upstream target of the mTOR pathway, mediates cell death in prion diseases through sustained translational inhibition.  Some evidence points to mTOR\u2019s role in reduced A\u03b2 clearance as well. mTOR is a negative regulator of autophagy; therefore, hyperactivity in mTOR signaling should reduce A\u03b2 clearance in the AD brain. Disruptions in autophagy may be a potential source of pathogenesis in protein misfolding diseases, including AD. Studies using mouse models of Huntington\u2019s disease demonstrate that treatment with rapamycin facilitates the clearance of huntingtin aggregates. Perhaps the same treatment may be useful in clearing A\u03b2 deposits as well.",
            "score": 183.41456604003906
        },
        {
            "docid": "56646747_2",
            "document": "The AIM center . The Autophagy, Inflammation and Metabolism (AIM) center is an NIH-funded Center of Biomedical Research Excellence focused on the study of autophagy as a fundamental biological process and how it intersects with metabolism and quality control processes in eukaryotic cells. A special emphasis is on the role or autophagy in a wide spectrum of diseases with metabolic, inflammatory and immunological aspects. At the fundamental level, autophagy is a cytoplasmic pathway for the disposal of damaged or surplus organelles such as mitochondria, peroxisomes, lysosomes, endoplasmic reticulum, ribosomes, protein aggregates and also serves as a catabolic process providing nutrients through autodigestion at times of starvation. Autophagy has been implicated in cancer, neurodegeneration such as Alzheimer's disease, Huntington's disease and Parkinson's disease, diabetes, development, infections and immune diseases, as well as a process of relevance for aging.",
            "score": 182.7517547607422
        },
        {
            "docid": "624361_18",
            "document": "Autophagy . Autophagy has roles in various cellular functions. One particular example is in yeasts, where the nutrient starvation induces a high level of autophagy. This allows unneeded proteins to be degraded and the amino acids recycled for the synthesis of proteins that are essential for survival. In higher eukaryotes, autophagy is induced in response to the nutrient depletion that occurs in animals at birth after severing off the trans-placental food supply, as well as that of nutrient starved cultured cells and tissues. Mutant yeast cells that have a reduced autophagic capability rapidly perish in nutrition-deficient conditions. Studies on the \"apg\" mutants suggest that autophagy via autophagic bodies is indispensable for protein degradation in the vacuoles under starvation conditions, and that at least 15 APG genes are involved in autophagy in yeast. A gene known as ATG7 has been implicated in nutrient-mediated autophagy, as mice studies have shown that starvation-induced autophagy was impaired in \"atg7\"-deficient mice.",
            "score": 182.6377716064453
        },
        {
            "docid": "4464817_17",
            "document": "Neurodegeneration . Autophagy is essentially a form of intracellular phagocytosis in which a cell actively consumes damaged organelles or misfolded proteins by encapsulating them into an autophagosome, which fuses with a lysosome to destroy the contents of the autophagosome. Many neurodegenerative diseases show unusual protein aggregates. This could potentially be a result of underlying autophagic defect common to multiple neurodegenerative diseases. It is important to note that this is a hypothesis, and more research must be done.",
            "score": 176.1075439453125
        },
        {
            "docid": "14723656_10",
            "document": "Granulin . Heterozygous mutation of the GRN gene leading to progranulin haploinsufficiency causes Frontal Temporal Dementia. These mutations include frameshift, splice site, nonsense signal peptide, Kozak sequence disruptions and missense mutations, which result in either nonsense-mediated decay or the production of non-functional protein. Patients with GRN caused FTD (GRN-FTD) exhibit asymmetric brain atrophy, although age of onset, disease progression and clinical symptoms vary, suggesting that other genetic or environmental factors may be involved in disease expression. Pathological indicators include cytosolic ubiquitin deposits enriched in hyperphosphorylated TAR DNA Binding Protein (TDP-43), autophagy-related protein aggregates, ubiquitin-binding protein p62, lentiform intranuclear inclusions, dystrophic neurites and inflammation. Patients with the heterozygote mutation exhibit a reduction of 70-80% serum progranulin levels when compared to controls. Reprogrammed stem cells restore GRN mRNA levels to 50%, further suggesting that some other genetic or environmental factor is involved in regulating FTD disease expression. Mice exhibit reduced autophagic flux and autophagy-dependent clearance. Human FTLD-GRN derived fibroblasts show decrease lysosomal protease activity and lymphoblasts containing neuronal ceroid lipofuscinosis-like storage material. FTLD-GRN IPSC cortical Neurons have enlarged vesicles, lipofuscin accumulation and cathepsin D deficiency.",
            "score": 175.59625244140625
        },
        {
            "docid": "38705478_5",
            "document": "Chaperone-assisted selective autophagy . Proteins that are degraded by chaperone-assisted selective autophagy include pathogenic forms of the Huntingtin protein, which cause Huntington's disease. Furthermore, the expression of the CASA-inducing cochaperone BAG3 is upregulated in aged neuronal cells, which correlates with an increased necessity to dispose oxidatively damaged proteins through autophagy. CASA is thus essential for proteostasis in neurons.",
            "score": 174.56504821777344
        },
        {
            "docid": "37860179_9",
            "document": "Chaperone-mediated autophagy . CMA is active at all times in different tissues (liver, kidney, brain), and almost all cell types in culture studied. However, it is maximally activated in response to stressors and changes in the cellular nutritional status. When nutrient supply is limited, the cells respond by activating autophagy, in order to degrade intracellular components to provide energy and building blocks, which the cell can utilize in this dire state. Macroautophagy is activated as early as 30 minutes into starvation and remains at high activity for at least 4\u20138 hours into starvation. If the starvation state persists for more than 10 hours, the cells switch to the selective form of autophagy, namely CMA, which is known to reach a plateau of maximal activation ~36 hours into fasting and remains at these levels until ~3 days. The selectivity of CMA for individual cytosolic proteins permits cells to degrade only those proteins that might not be required in these starvation conditions in order to generate amino acids for the synthesis of essential proteins. For example, some of the best-characterized CMA substrates are enzymes involved in glycolysis, a pathway known to be less active in fasting conditions.",
            "score": 174.55987548828125
        },
        {
            "docid": "55895027_5",
            "document": "Disposable soma theory of aging . Much research has been done on the antagonistic effects of increased growth on lifespan. Specifically, the hormone insulin-like growth factor 1 (IGF-1), binds to a cell receptor, leading to a phosphorylation cascade. This cascade results in kinases phosphorylating forkhead transcription factor (FOXO), deactivating it. Deactivation of FOXO results in an inability to express genes involved in responding to oxidative stress response, such as antioxidants, chaperones, and heat-shock proteins.  Additionally, uptake of IGF-1 stimulates the mTOR pathway, which activates protein synthesis (and therefore growth) through upregulation of the translation-promoting S6K1, and also inhibits autophagy, a process necessary for recycling of damaged cellular products. Decline of autophagy causes neurodegeneration, protein aggregation and premature aging. Lastly, studies have also indicated that the mTOR pathway also alters immune responses and stimulates cyclin-dependent kinase (CDK) inhibitors such as p16 and p21. This leads to alteration of the stem-cell niche and results in stem cell exhaustion, another theorized mechanism of aging.",
            "score": 173.5143280029297
        },
        {
            "docid": "624361_15",
            "document": "Autophagy . In mammals, amino acid sensing and additional signals such as growth factors and reactive oxygen species regulate the activity of the protein kinases mTOR and AMPK. These two kinases regulate autophagy through inhibitory phosphorylation of the Unc-51-like kinases ULK1 and ULK2 (mammalian homologues of Atg1). Induction of autophagy results in the dephosphorylation and activation of the ULK kinases. ULK is part of a protein complex containing Atg13, Atg101 and FIP200. ULK phosphorylates and activates Beclin-1 (mammalian homologue of Atg6), which is also part of a protein complex. The autophagy-inducible Beclin-1 complex contains the proteins p150, Atg14L and the class III phosphatidylinositol 3-phosphate kinase (PI(3)K) VPS34. The active ULK and Beclin-1 complexes re-localize to the site of autophagosome initiation, the phagophore, where they both contribute to the activation of downstream autophagy components.",
            "score": 173.4728240966797
        },
        {
            "docid": "624361_21",
            "document": "Autophagy . Autophagy degrades damaged organelles, cell membranes and proteins, and the failure of autophagy is thought to be one of the main reasons for the accumulation of damaged cells and aging.",
            "score": 173.29013061523438
        },
        {
            "docid": "18048149_16",
            "document": "Protein aggregation . Most of the protein aggregates in yeast cells get refolded by molecular chaperones. However, some aggregates, such as the oxidatively damaged proteins or the proteins marked for degradation, cannot be refolded. Rather, there are two compartments that they can end up in. Protein aggregates can be localized at the Juxtanuclear quality-control compartment (JUNQ), which is near the nuclear membrane, or at the Insoluble Protein deposit (IPOD), near the vacuole in yeast cells. Protein aggregates localize at JUNQ when they are ubiquitinated and targeted for degradation. The aggregated and insoluble proteins localize at IPOD as a more permanent deposition. There is evidence that the proteins here may be removed by autophagy. These two pathways work together in that the proteins tend to come to the IPOD when the proteasome pathway is being overworked.",
            "score": 172.2867889404297
        },
        {
            "docid": "2448941_47",
            "document": "Cancer stem cell . Studies looked for specific markers and for proteomic and genomic tumor signatures that distinguish CSCs from others. In 2009, scientists identified the compound salinomycin, which selectively reduces the proportion of breast CSCs in mice by more than 100-fold relative to Paclitaxel, a commonly used chemotherapeutic agent. Some types of cancer cells can survive treatment with salinomycin through autophagy, whereby cells use acidic organelles such as lysosomes to degrade and recycle certain types of proteins. The use of autophagy inhibitors can kill cancer stem cells that survive by autophagy.",
            "score": 171.2587890625
        },
        {
            "docid": "624361_7",
            "document": "Autophagy . The field of autophagy research experienced accelerated growth at the turn of the century. Knowledge of ATG genes provided scientists more convenient tools to dissect functions of autophagy in human health and disease. In 1999, a landmark discovery connecting autophagy with cancer was published by Beth Levine\u2019s group. To this date, relationship between cancer and autophagy continues to be a main theme of autophagy research. The roles of autophagy in neurodegeneration and immune defense also received considerable attention. In 2003, the first Gordon conference on autophagy was held at Waterville. In 2005, Daniel J Klionsky launched \u201cAutophagy\u201d, a scientific journal dedicated to this field. The first Keystone Symposia on autophagy was held in 2007 at Monterey. In 2008, Carol A Mercer created a BHMT fusion protein (GST-BHMT), which showed starvation-induced site-specific fragmentation in cell lines. The degradation of betaine homo-cysteine methyltransferase (BHMT), a metabolic enzyme, could be used to assess autophagy flux in mammalian cells.",
            "score": 169.8123321533203
        }
    ]
}